Johanne A. Windelov

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Development of a long-acting unbiased GIP receptor agonist for studies of GIP's role in bone metabolism.

Development of a long-acting unbiased GIP receptor agonist for studies of GIP's role in bone metabolism.

Journal: Biochemical pharmacology

Published: December 19, 2024

Effects of Exogenous GIP and GLP-2 on Bone Turnover in Individuals With Type 2 Diabetes.

Effects of Exogenous GIP and GLP-2 on Bone Turnover in Individuals With Type 2 Diabetes.

Journal: The Journal of clinical endocrinology and metabolism

Published: May 09, 2023

Long-acting agonists of human and rodent GLP-2 receptors for studies of the physiology and pharmacological potential of the GLP-2 system.

Long-acting agonists of human and rodent GLP-2 receptors for studies of the physiology and pharmacological potential of the GLP-2 system.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 01, 2022

Expression Profile of the GLP-1 Receptor in the Gastrointestinal Tract and Pancreas in Adult Female Mice.

Expression Profile of the GLP-1 Receptor in the Gastrointestinal Tract and Pancreas in Adult Female Mice.

Journal: Endocrinology

Published: July 22, 2021

Glucose-dependent insulinotropic polypeptide receptor antagonist treatment causes a reduction in weight gain in ovariectomised high fat diet-fed mice.

Glucose-dependent insulinotropic polypeptide receptor antagonist treatment causes a reduction in weight gain in ovariectomised high fat diet-fed mice.

Journal: British journal of pharmacology

Published: May 25, 2021

Antagonizing somatostatin receptor subtype 2 and 5 reduces blood glucose in a gut- and GLP-1R-dependent manner.

Antagonizing somatostatin receptor subtype 2 and 5 reduces blood glucose in a gut- and GLP-1R-dependent manner.

Journal: JCI insight

Published: August 18, 2020

Novel agonist and antagonist radioligands for the GLP-2 receptor. Useful tools for studies of basic GLP-2 receptor pharmacology.

Novel agonist and antagonist radioligands for the GLP-2 receptor. Useful tools for studies of basic GLP-2 receptor pharmacology.

Journal: British journal of pharmacology

Published: August 18, 2020

Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis.

Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis.

Journal: Molecular metabolism

Published: July 10, 2020

Pharmacological activation of TGR5 promotes intestinal growth via a GLP-2-dependent pathway in mice.

Pharmacological activation of TGR5 promotes intestinal growth via a GLP-2-dependent pathway in mice.

Journal: American journal of physiology. Gastrointestinal and liver physiology

Published: April 21, 2020

Enteroendocrine K Cells Exert Complementary Effects to Control Bone Quality and Mass in Mice.

Enteroendocrine K Cells Exert Complementary Effects to Control Bone Quality and Mass in Mice.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: January 14, 2020

Glucagon-Like Peptide 1 and Atrial Natriuretic Peptide in a Female Mouse Model of Obstructive Pulmonary Disease.

Glucagon-Like Peptide 1 and Atrial Natriuretic Peptide in a Female Mouse Model of Obstructive Pulmonary Disease.

Journal: Journal of the Endocrine Society

Published: August 26, 2019

Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment.

Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment.

Journal: Frontiers in endocrinology

Published: September 20, 2018

Showing 1-12 of 25

Last Updated: 09/26/2026